Clinical Trials · NCT07460752

Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients

Name: Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

RecruitingPhase 2Gonadorelin

Phase: Phase 2
Recruitment status: Recruiting
Sponsor: Mayo Clinic
Enrollment: 98
Start date: May 2026
Locations: 1 site, United States
Primary endpoint: Ovarian function suppression (OFS) maintenance

View Gonadorelin compound reference